The Bcr-Abl fusion protein plays a crucial role in the initiation and maintenance of chronic myelogenous leukemia (CML). However, additional events are necessary for the transition from the chronic phase to the terminal phase of the disease. To identify genes involved in the disease progression, we constructed a subtractive library from enriched K562 cell mRNA. 
Introduction
Chronic myelogenous leukemia (CML) is a myeloproliferative disorder characterized by the accumulation of mature granulocytes and their precursors in bone marrow, blood and spleen. The Philadelphia chromosome (Ph), a foreshortened chromosome 22, is the cytogenetic hallmark of CML and identifies a reciprocal translocation between chromosomes 9 and 22. The Ph chromosome results in the in-frame fusion of 5Ј exons of bcr (at 22q11) with the 3Ј exons of abl (at 9q34). The bcr-abl hybrid gene is transcribed into a 8.5 kb mRNA in which exon 1 of abl is replaced by 5Ј bcr exons.
The hybrid gene encodes a 210 kDa protein (called p210 bcr-abl ) with dysregulated tyrosine kinase and actin-binding functions that are crucial for the transforming potential.
liferation of the myeloid lineage with a normal differentiation. In the absence of treatment and after several years, the chronic phase is invariably followed by a blast crisis, indistinguishable from acute leukemia: an accumulation of immature blast cells of both myeloid and lymphoid origins is observed. Therefore, secondary events are required to induce the full tumorigenic phenotype as seen in the terminal stage. Most acute phase leukemias are associated with additional cytogenetic abnormalities. These chromosomal aberrations may promote alterations in tumor suppressor genes such as p53. 7, 8 Nevertheless, the factors that cause the blast crisis are not well understood.
The aim of this work was to comprehend the molecular events involved in the progression of the disease, from the chronic phase to the acute one. We describe here the construction of a cDNA library obtained from mRNA extracted from K562 cells subtracted with cDNA prepared from chronic phase cells. We detail the isolation and the characterization of overexpressed cDNA clones identified by differential hybridization. This strategy allowed the detection of several genes differentially expressed during progression of chronic myelogenous leukemia.
In this report, we analyze expression of some identified cDNA clones corresponding to ribosomal proteins, MAZ protein and a laminin-binding protein.
Patients and methods

Patients
Eight cytogenetically and morphologically confirmed CML patients were included in this study. Five patients were in chronic phase and three were studied while in acute phase which was of myelogenous type (Table 1) . Peripheral blood samples or spleen cells were collected after informed consent had been obtained from the patients.
Cells, cell lines and tissues
The subtractive library was constructed using spleen cells and the K562 cell line. We chose these cells to ensure we had sufficient amounts of starting RNA material for the first steps of the experiment. Spleen cells came from a surgical specimen of a CML patient in chronic phase. This tissue presented only a myeloid metaplasia and contained mature granulocytes and myeloid precursors characteristic of the first stage of the disease. The acute phase derived K562 cell line was used as starting material. This line presents the advantage of being an unlimited source of mRNA, even if it may not completely represent CML blast crisis cells. 
RNA extraction
Mononuclear cells from peripheral blood were isolated over a lymphocytes separation medium (1.077 g/ml; Eurobio). The mononuclear cells at interface were collected and washed in cold phosphate-buffer saline (PBS) before RNA extraction. Total cellular RNA from spleen was isolated by centrifugation through a CsCl cushion as described by Chirgwin et al. 9 Total RNA from blood cells and from the K562 cell line was isolated by the RNA B technique (Bioprobe System). Poly(A) + mRNA was purified using the oligotex-(dT) 30 kit (Qiagen).
Preparation of the subtractive cDNA library
For the construction of the subtractive library, we performed all the reactions in a single microcentrifuge tube using the oligotex-(dT) 30 suspension (O-dT). First, 16 g of mRNA from spleen cells were mixed with O-dT. Reverse transcription was performed directly on the mRNA bound to the beads as previously described. 10 After RNA removal by heating and two washes, the cDNA was ready to use for the subtraction. The cDNA-O-dT was resuspended in 90 l of TE buffer containing 100 g of pd(A) [25] [26] [27] [28] [29] [30] (Pharmacia) to mask oligo(dT) residues. After washing, the beads were resuspended in 200 l of hybridization buffer (10 mM Tris-HCl (pH 7.5); 150 mM NaCl; 1 mM EDTA) and 2 g of mRNA extracted from the K562 cell line were added. The hybridization reaction was performed at 55°C for 20 min. After centrifugation, the supernatant was collected. It represents the first subtractive mRNA fraction (S1). The beads were heated to dissociate the mRNA-cDNA-O-dT duplex and a second hybridization was performed with the S1 fraction. After centrifugation, the supernatant was collected and the second subtractive mRNA fraction was extracted with phenol/chloroform and precipitated with ethanol. The subtractive mRNA was mixed in 20 l of a reaction mixture containing 50 mM Tris-HCl (pH 8.3), 75 mM KCl, 3 mM MgCl 2 , 10 mM DTT, 20 units of human placental RNase inhibitor, 10 mM of each dNTP, 1.6 g of oligo(dT) and 200 units of M-MLV reverse transcriptase (GIBCO). The reaction was carried out at 37°C for 90 min. The second strand was synthesized with the cDNA synthesis system plus kit (Amersham). The double strand cDNA was then cloned into the gt10 vector using the cDNA cloning system kit (Amersham).
Differential screening and preparation of the inserts
The subtractive library was screened with both chronic phase and K562 cDNA probes. These probes were obtained by reverse transcription of mRNA from spleen cells of a patient in chronic phase and from K562 cell line. For each Petri dish, two transfers onto Nylon filters (Hybond N + ; Amersham) were performed as recommended by the manufacturer. One filter was hybridized with the chronic phase cDNA probe, the second one with the acute phase cDNA probe. Singlestranded ( 32 P)-labeled cDNA probes were synthesized as follows: 4 g of mRNA were incubated for 90 min at 37°C in 50 mM Tris-HCl (pH 8.3), 75 mM KCl, 3 mM MgCl 2 , 10 mM DTT, 0.6 units of human placental RNase inhibitor, 20 M of dATP, dGTP, dTTP, 0.8 M dCTP, 4 g of oligo(dT), 60 Ci of ␣-32 P-dCTP and 400 units of M-MLV reverse transcriptase (GIBCO). We selected clones giving different hybridization signals with both probes. Clones were submitted to PCR using the following primers: gt10 forward primer (LgA): 5Ј GCTGGGTAGTCCCCACCTTT 3Ј and gt10 reverse primer (LgB): 5Ј CTTATGAGTATTTCTTCCAGGGT 3Ј. These primers were located on both sides of the EcoRI cloning site of gt10. PCR reactions were performed as follows: phage lysate was added to a total volume of 50 l containing 50 mM KCl, 20 mM Tris-HCl (pH 8.3), 2 mM MgCl 2 , 250 M of each dNTP, 100 ng of each primer and 2.5 units of Taq polymerase (Perkin-Elmer Cetus). After a classical 30 cycles amplification, PCR products were partially sequenced using the sequenase PCR product sequencing kit (USB). Homologous sequences were sought in the EMBL and GenBank databases.
Northern blot analysis
For each positive clone, we tested several samples including non-CML control, CML patients in chronic phase, CML patients in acute phase and the K562 cell line. Samples of non-CML control came from anonymous volunteer donors with normal blood formula. For CML patients in chronic phase and in acute phase, we have mixed RNA samples from different patients (two or three) in the same phase of CML with the aim to overcome some individual variations in gene expression. One g of each mRNA sample was electrophoresed on a 1% agarose denaturing gel and blotted onto nitrocellulose membrane (Hybond C extra; Amersham). Pre-328 hybridization and hybridization were performed as recommended. The different probes were prepared from PCR purified products and radiolabeled with ␣-32 P-dCTP by random priming (Multiprime; Amersham). Membranes were also probed with ␤-actin cDNA to correct the variability in RNA loading.
Results
The subtractive library technique was used to identify genes differentially expressed during CML progression and essentially overexpressed in the blast crisis. The library was obtained after subtraction of mRNA from the K562 cell line with cDNA prepared from mRNA extracted from the spleen of a patient in chronic phase. To perform this subtraction, we chose an efficient and accurate technique based on oligotex (dT) beads. After two steps of hybridization, we eliminated most of the mRNA common to both chronic phase and K562 cells. The enriched specific mRNA of K562 was then used to construct the subtractive library in gt10. We obtained around 2000 clones. They were rearranged at 400 phage plaques per Petri dish to facilitate their analysis.
In order to select recombinant phages with insert, PCR were performed using LgA and LgB primers. For 1181 recombinants we obtained PCR products ranging from 300 bp to 2 kb. The mitochondrial inserts were identified by hybridizing these PCR products with a mitochondrial mouse DNA probe of 16.3 kb cloned in the pAM 1 vector. Finally, 1084 clones were obtained and picked up.
Characterization of the subtractive clones
Duplicate filters of the rearranged clones were hybridized with either chronic phase or K562 cDNA probes. The hybridization signals of the two probes were compared for each plaque. We selected 43 clones presenting a high differential expression level between chronic phase and K562 cells. The insert from each selected clone was amplified using gt10 forward and reverse primers. All the PCR products are included between 200 and 1200 bp length. They were partially sequenced.
Comparison with the Genbank and EMBL databases showed that most clones had significant nucleotide identity with known registered sequences ( Table 2 ). In this report we emphasized cDNA coding for three types of identified proteins.
Twenty-two cDNA corresponded to 14 different ribosomal proteins: L7a, L12, L21, L37a, S2, S3, S4, S8, S10, S17, S18, S19, P0 and P1. The homology covered in part the coding regions of these different cDNA.
Four other clones appeared to represent the same gene. Their sequences presented high homology with a potential laminin-binding protein gene. These inserts were identical in pairs. The size of inserts from clones XIIC5 and XIID9 was 1000 bp and the sequence comprised nearly the full-length laminin-binding protein coding region. 11 The 450 bp inserts from XP15 and XR12 clones contained both the 3Ј coding and non-coding region of the transcript.
The XIIF3 clone encoded a Myc regulator protein: MAZ (Myc-associated zinc finger protein). This insert contained 73 bp from the coding region and 857 bp from the 3Ј untranslated region of the mRNA. Other clones, although identified and mentioned in Table  1 , will be further studied.
Northern blot analysis
The subtractive library was constructed with mRNA from K562 cells. We are aware that this line can differ from blast cells of a patient in acute phase. However, it was recently shown that many of the differences that distinguish normal from tumor cells in vivo persist during in vitro growth. 12 Moreover we have performed Northern blot analyses in order to verify the gene expression differences between the acute and chronic phase.
Thus, Northern blots were performed, and the expression level of S10 and P0 ribosomal proteins, laminin-binding protein and MAZ genes were studied in normal subjects, in chronic and acute phase patients and in K562 cell line (Table 3 ).
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Table 3
Expression level of four genes during the progression of CML Ribosomal proteins: Among the 22 cDNA clones, corresponding to 14 genes, we show the expression of two of them (S10 and P0) (Figures 1 and 2 ). The expression of ribosomal protein genes increases from normal cells to acute phase cells and the K562 cell line. The transcript revealed with the XC17 cDNA probe, corresponding to the S10 ribosomal protein, is present at a very high amount during the acute phase and in K562 cell line. The 1.1 kb transcript, revealed by the XIR8 cDNA probe, corresponding to the P0 ribosomal protein, was at a high level in chronic phase as compared to the normal sample. Its level slightly increased during the acute phase and was at a higher level in K562 cells.
Laminin-binding protein:
The XP15 and XR12 clones were identical to the 3Ј regions (coding and non-coding) of the fulllength cDNA published by Yow et al. 11 They hybridized in the different samples with two types of RNA (1.2 kb and 5.5 kb) and both had the same expression pattern during the
Figure 1
Northern blot analysis of ribosomal protein S10 gene expression. RNA samples from non-CML control (1), chronic phase CML (2), acute phase CML (3), and K562 cell line (4) were hybridized with 32 P-labeled cDNA encoding the ribosomal protein S10. Hybridization of the filter with a ␤-actin probe was performed as a control. evolution of CML (Figure 3a) . They appeared significantly underexpressed in the chronic phase sample with regard to the normal sample. This decreased expression was particularly obvious for the 5.5 kb RNA since it was more expressed in the normal control than the smaller RNA. The hybridization level of both RNAs increased during the acute phase of CML and in K562 cells, the one for the 1.2 kb RNA overtaking those of the normal control.
The cDNA sequence of the XIIC5 and XIID9 clones corresponded to the 3Ј coding region of the full-length cDNA.
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The XIIC5 and XIID9 clones (Figure 3b ) only revealed the 1.2 kb transcript in all the RNA samples with the same evolution pattern as for the XP15 and XR12 clones.
MAZ protein:
The XIIF3 cDNA clone, corresponding to the MAZ protein gene, revealed a 2.5 kb mRNA (Figure 4) . It was present at a faint level in normal and chronic samples, while an important increase of the expression occurred during
Figure 2
Northern blot analysis of ribosomal protein P0 gene expression. RNA samples from non-CML control (1), chronic phase CML (2), acute phase CML (3) and K562 cell line (4) were hybridized with 32 P-labeled cDNA encoding the ribosomal protein P0. Hybridization of the filter with a ␤-actin probe was performed as a control.
Figure 3
Northern blot analysis of laminin-binding protein gene. RNA samples from non-CML control (1), chronic phase CML (2), acute phase CML (3) and K562 cell line (4) were hybridized with 32 P-labeled cDNA of XP15 clone (a) and XIIC5 (b). Hybridization of the filters with a ␤-actin probe was performed as a control.
Figure 4
Northern blot analysis of MAZ protein gene expression. RNA samples from non-CML control (1), chronic phase CML (2), acute phase CML (3) and K562 cell line (4) were hybridized with 32 P-labeled cDNA encoding the MAZ protein. Hybridization of the filter with a ␤-actin probe was performed as a control.
the acute phase and in K562 sample. Furthermore, an additional transcript of 0.5 kb was detected only in K562 cells. This mRNA of small size had been previously detected in some tissues, such as the brain and pancreas. 13 
Discussion
In this work we used the subtractive library technique to identify genes differentially expressed during CML progression and essentially overexpressed in the blast crisis. The high amount of material required for this technique required us to use a cell line (K562) and spleen cells of a patient as starting materials. We are aware that these cells could differ from patient cells. However, it was recently shown that many of the differences that distinguish normal from tumor cells in vivo persist during in vitro growth, which demonstrates the utility of cultured cell lines for examination of some aspects of gene expression. 12 Moreover, Northern blots were performed to ascertain the observed differences in gene expression.
The library was obtained using the oligotex (dT) bead technique. After two steps of hybridization, we eliminated most of the mRNA common to both cell types. This technique allowed us to clone 1084 inserts. A specific hybridization with either a chronic phase cDNA probe or a K562 cDNA probe revealed differences in gene expression between these two phases. We have chosen to analyze the 43 clones presenting the most differences between the two phases. All these clones were sequenced and Northern blot analyses were performed using these clones as a probe on RNA from normal cells, chronic and acute phase patients and K562 cells. It is possible that some of the 1041 remaining inserts could be important to the understanding of the progression of the disease; but as the difference in their expression was less significant compared to those of our first choice, they were not retained. Other investigations with these inserts should be undertaken.
Many selected clones represent ribosomal protein mRNA. We observed that L7a, L12, L21, L37a, S3, S4, S8, S10, S17, S18, S19, S21, P0 and P1 ribosomal genes are overexpressed during CML and especially in the terminal phase of the disease compared with normal cells. The increased transcription of ribosomal protein genes, such as P0, S3, S6, S8, S12, S18, L27a, L31 and L37 has been previously described in hepatocellular and colorectal carcinomas. [14] [15] [16] [17] These data suggest that cells in active proliferation need an increase in ribosomal biogenesis in order to permit an activate protein synthesis. Although there were many published results about ribosomal protein gene expression in solid tumors, it was not the case for leukemias. Our results suggest that, as for solid tumors, an active ribosomal protein synthesis is required for the proliferation of cells in CML, and more so during the acute phase than during the chronic phase. The increased synthesis of ribosomal proteins probably does not contribute to the transition to blast crisis, but is more likely the consequence of this transition.
Some other clones were particularly studied. Four clones, identical in pairs, were identified corresponding to a lamininbinding protein cDNA. We have shown a decreased expression of this gene during the chronic phase.
Normal hematopoiesis depends on complex interactions between stem cells and the bone marrow environment. It has been demonstrated that direct contact between normal progenitors and marrow stroma is important for negative regulation of progenitor growth. Stroma cells can induce proliferation and differentiation of stem cells by releasing factors, but can also inhibit the proliferation by direct cell-cell interaction. 18 As opposed to the normal primitive hematopoietic progenitors that are usually quiescent when present in close contact with marrow stroma, it has been shown that Phpositive progenitors escape from this negative control. 19 This abnormal behavior is the result of an altered adhesive interaction between hematopoietic progenitor CML cells and stromal elements. 20 This lead to a premature release of primitive progenitors and precursors in the peripheral blood and to the continuous proliferation of the malignant population. Thus, adhesion molecules play a key role in maintaining a normal hematopoiesis. It has already been shown that primitive progenitors from CML bone marrow fail to adhere to fibronectin. This failure is not due to a decreased expression of the fibronectin receptor but to an alteration of its function.
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Interferon-␣ (IFN-␣) restores adhesion between Ph progenitor cells and stromal cells by modulating ␤1 integrin receptor function. 22 The precise mechanisms by which IFN-␣ restores normal hematopoiesis in CML is not well understood. Bhatia et al 22 have demonstrated that IFN-␣ acts directly on CML hematopoietic progenitors to restore their adhesion to marrow stroma by modulating ␤1 integrin receptor functions.
CML must be considered in two distinct phases because of differences observed on proliferation and differentiation of myeloid precursors. Interestingly, we observed an important difference in the expression level of the laminin receptor gene in the different stages of CML. In fact, our study revealed a decreased expression of this receptor during the chronic phase of the CML; this expression arose during the acute phase. Our study and others provide strong evidence that altered integrin expression is closely linked to the malignant phenotype. The decreased expression of laminin-binding protein gene observed in chronic phase could be responsible for the noncontrolled proliferation, characteristic of the first step of CML.
Another overexpressed gene in the acute phase is the MAZ protein gene. This protein binds specifically to the ME1a1 sequence found in the c-myc P2 promoter. 13 The fixation of the MAZ protein to the ME1a1 site has two effects: the activation of myc transcription from P2 promoter and the inhibition of myc transcription from P1 promoter. In Bcr-Abltransformed cells, transcription initiation occurred essentially from the P2 promoter. Our results suggest an important role of MAZ in the regulation of myc expression during transition from the chronic phase to the acute phase of CML. Other investigations are under way to demonstrate that increased levels of c-myc are in accordance with the increased levels of MAZ in the acute phase of CML.
Integrin-dependent signaling pathways control cell differentiation, proliferation and survival. The cytoskeleton is involved in these pathways. For this reason it seems important to mention that we isolated two genes (␤4-thymosin and lipoxygenase), which are involved in the organization of actin cytoskeleton. We observed differences in the gene expression level during CML progression suggesting an inhibition of actin polymerization during the acute phase.
In conclusion, we have identified several genes with potential action on CML progression. The genes we discussed in this report encode ribosomal proteins, a cell adhesion protein, or a transcription factor. It is well known that cell metabolism is regulated by cell-cell and cell-extracellular matrix interactions. Proteins involved in this normal process can also have an essential role in malignant evolution. At the present time, this hypothesis has been extensively studied in solid tumors such as colorectal cancer. In this work, we emphasize that a similar mechanism could occur in the development of leukemias. We are currently extending the studies of the transcription level of the described genes in a series of CML chronic phase and acute phase patients and in different hematopoietic disorders. Further analysis of genes involved in CML progression could provide important data for understanding the molecular events leading to the acute phase of the disease.
